Article
miR‑10a‑5p inhibits osteogenic differentiation of bone marrow‑derived mesenchymal stem cells
4 May 2020
Abstract excerpt
The use of human bone marrow mesenchymal stem cells (hBMSCs) as a tissue engineering application for individuals affected by osteoporosis and other types of bone loss diseases has been well studied in recent years. The osteogenic differentiation of hBMSCs can be regulated by a number of cues. MicroRNAs (miRNAs/miRs) serve as the key regulators of various biological processes; however, to the best of our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
